Current guidelines from the Food and Drug Administration (FDA) state that, “In the context of the donor history questionnaire, FDA recommends that male or female gender be taken to be self-identified and self-reported”. This guideline allows blood donors to respond to the questionnaire based on the gender with which they identify.
The New York Blood Center values all potential blood donors and understands that male or female sex assigned at birth may not align with how some individuals currently identify. There is no deferral associated with being transgender, intersex or gender non-conforming, however the FDA requires all donors select either male or female gender and answer the questions accordingly. Eligibility will be determined based upon the criteria associated with the gender the donor has reported.
If our records have the incorrect gender, presenting donors may ask staff members to make the change upon registration. Individuals do not need to tell staff that they are transgender, intersex or gender non-conforming.
Individuals with specific questions about eligibility to donate blood are encouraged to contact Special Donor Services at 800-688-0900, Monday through Friday 9am – 5pm.